Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AssayMetrics and Cambridge Research Biochemicals Collaborate

Published: Monday, October 08, 2012
Last Updated: Monday, October 08, 2012
Bookmark and Share
Collaboration in the field of Fluorescence Lifetime technology.

AssayMetrics Ltd has announced collaboration with Cambridge Research Biochemicals Ltd, the UK’s most established peptide and antibody company.

Fluorescence Lifetime is a new and assay technology used in the biochemical screening of new drugs in High Throughput Screening and compound characterization roles in the pharmaceutical industry.

The collaboration involves Cambridge Research Biochemicals making key peptide substrates labelled with AssayMetrics’ Fluorescence Lifetime dyes.

The peptides are used to screen novel drugs in equipment such as AssayMetrics’ Fluospec® FL reader and are employed in assays involving kinases, proteases, protein:protein interactions and other target enzyme systems.

The collaboration brings together two companies leading their respective fields to be able to offer solutions to the pharmaceutical industry enabling faster, more efficient and cheaper drug discovery and development, thereby improving the effectiveness of pharmaceutical R&D.

Dr Pierre Graves, MD of AssayMetrics Ltd commented, “This is exciting news as Cambridge Research Biochemicals have considerable expertise in making the type of complex peptides needed for innovative discovery.”

Emily Humphrys, Commercial Director of Cambridge Research Biochemicals was equally positive: “This technology has so much potential that we are really pleased to be collaborating with AssayMetrics at this early stage.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

CRB Signs Deal with LI-COR Biosciences
License to develop, manufacture and sell IRDye® and IRDye® QC-1 near-infrared dye-labelled peptides.
Monday, July 09, 2012
RCUK SSC Ltd Extends Contract with CRB
CRB to supply custom synthesized peptides and polyclonal and monoclonal antibodies for a further 12 months.
Tuesday, May 15, 2012
CRB Signs Exclusive Japanese Distribution Deal with BioBridge
BioBridge to be responsible for the sales and marketing of CRB’s products in Japan.
Friday, March 30, 2012
CRB Signs Agreement with Life Technologies
Cambridge Research Biochemicals sign an extension to its Supply & Licence Agreement with Life Technologies - Molecular Probes, significantly expanding its dye labelling offering.
Friday, January 20, 2012
Cambridge Research Biochemicals Appointed as Peptide and Antibody Supplier by RCUK SSC Ltd
The new two-year contract appoints CRB as a key supplier of custom synthesized peptides and custom generated polyclonal and monoclonal antibodies.
Thursday, June 17, 2010
Scientific News
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
‘NoBody,’ a Microprotein On a Mission
Researchers identify over 400 microproteins encoded in the human genome, one of which clears unneeded genetic material inside cells.
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
Largest Resource of Protein-Protein Interactions
Researchers have developed the largest ever database of protein-protein interactions.
Bright Red Fluorescent Protein Created
Scientists have created a bright red, fluorescent protein that could be used to track essential cellular processes.
Protein Self-Regulates Abundance
Researchers have uncovered how a protein, that plays a crucial role in embryonic stem cell renewal, is regulated.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Building Better Nanodiscs
Researchers have improved upon the design of nanodiscs that provide an unprecedented view of viral infection.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!